This inventor holds 2 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, The General Hospital Corporation. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 8,594 
2 out of 3,076 
Years Active: 1998-1999
Title: The Innovations of Margaret Magendantz
Introduction
Margaret Magendantz is a notable inventor based in Summerville, MA (US). She has made significant contributions to the field of biomedical research, particularly in the study of amyloid precursor-like proteins. With a total of 2 patents, her work has implications for understanding and potentially treating Alzheimer's disease.
Latest Patents
Margaret's latest patents include innovations related to amyloid precursor-like proteins (APLPs). The first patent focuses on isolated APLPs, nucleotide sequences coding for these proteins, and antibodies directed against them. This invention also encompasses recombinant vectors and host cells that contain the genetic sequences necessary for regulating the expression of these proteins. Additionally, it includes isolated genomic DNA, cDNA, anti-sense RNA, and RNA containing the protein sequence. These antibodies can be utilized to detect APLPs in various biological specimens, such as fluid, serum, or tissue samples. APLP1 and APLP2 are identified as candidate genes for late-onset familial Alzheimer's disease. The second patent similarly addresses isolated APLPs and their applications, reinforcing the importance of this research in the context of Alzheimer's disease.
Career Highlights
Throughout her career, Margaret has worked with esteemed organizations, including The General Hospital Corporation and the Massachusetts Institute of Technology. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Margaret has collaborated with notable colleagues such as Wilma Wasco and Keith Bupp. These partnerships have further enriched her research and innovation efforts.
Conclusion
Margaret Magendantz's contributions to the field of biomedical research, particularly through her patents on amyloid precursor-like proteins, highlight her role as a significant inventor. Her work not only advances scientific understanding but also holds promise for future therapeutic developments in Alzheimer's disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile